XVIVO has been recognized with two prestigious Davey Awards: A Gold for an animation showcasing a target to address hyperexcitability in epilepsy and a Silver for an animation illustrating the mechanism of action for a treatment targeting WHIM Syndrome.
, /PRNewswire-PRWeb/ — XVIVO, a trusted leader in digital animation and marketing for the life sciences industry announced today that the Academy of Interactive and Visual Arts has selected XVIVO as a Gold Davey Award winner for their Mechanism of Disease (MOD)/Mechanism of Action (MOA) animation created for Biohaven’s BHV-7000 molecule. XVIVO also received a Silver Davey Award for its collaboration with X4 Pharmaceuticals, showcasing the MOA of XOLREMDI, a treatment for WHIM Syndrome.
XVIVO earns Gold and Silver Davey Awards for their medical animations that bring complex science to life, showcasing the innovative mechanisms behind Biohaven’s BHV-7000 and X4 Pharmaceuticals’ XOLREMDI™
A Gold award was given for an MOD/MOA animation …